Assenagon Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.63M | Buy |
|
|||||
|
2024
Q4 | $957K | Sell |
|
|||||
|
2024
Q3 | $61.8M | Buy |
|
|||||
|
2024
Q2 | $28.2M | Sell |
|
|||||
|
2024
Q1 | $119M | Sell |
|
|||||
|
2023
Q4 | $128M | Buy |
|
|||||
|
2023
Q3 | $38.9M | Buy |
|
|||||
|
2023
Q2 | $45.4M | Sell |
|
|||||
|
2023
Q1 | $49M | Buy |
|
|||||
|
2022
Q4 | $37.6M | Sell |
|
|||||
|
2022
Q3 | $83.7M | Buy |
|
|||||
|
2022
Q2 | $39.9M | Buy |
|
|||||
|
2022
Q1 | $26.1M | Buy |
|
|||||
|
2021
Q4 | $3.18M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $14.9M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $496K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $586K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $6.03M | Buy |
|